Eugenio Villa
IRCCS Ospedale San Raffaele · 96 works · 3,981 citations · h-index 34
Top works
- Gefitinib in Pretreated Non–Small-Cell Lung Cancer (NSCLC): Analysis of Efficacy and Correlation With HER2 and Epidermal Growth Factor Receptor Expression in Locally Advanced or Metastatic NSCLC
- Primary cardiac lymphoma in immunocompetent patients
- Labeling Index as a Prognostic Marker in Non-Hodgkin's Lymphomas 2 , 3 , 4
- Carbohydrate antigen 19‐9 change during chemotherapy for advanced pancreatic adenocarcinoma
- Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial
- Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment
- Significant correlation between rectal DVH and late bleeding in patients treated after radical prostatectomy with conformal or conventional radiotherapy (66.6–70.2 Gy)
- Regression of Ocular Adnexal Lymphoma AfterChlamydia Psittaci–Eradicating Antibiotic Therapy
- Salvage chemotherapy with temozolomide in primary CNS lymphomas: preliminary results of a phase II trial
- Pharmacogenetics of ABCG2 and Adverse Reactions to Gefitinib
- Combined Treatment with High-Dose Methotrexate, Vincristine and Procarbazine, without Intrathecal Chemotherapy, Followed by Consolidation Radiotherapy for Primary Central Nervous System Lymphoma in Immunocompetent Patients
- Importance of complete staging in non-Hodgkin's lymphoma presenting as a cerebral mass lesion
- Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma
- Lethal pulmonary complications significantly correlate with individually assessed mean lung dose in patients with hematologic malignancies treated with total body irradiation
- A multicenter study of the prognosis and treatment of adult brain ependymal tumors
- A randomized phase II trial of two different 4-drug combinations in advanced pancreatic adenocarcinoma: cisplatin, capecitabine, gemcitabine plus either epirubicin or docetaxel (PEXG or PDXG regimen)
- Intraoperative and postoperative radiotherapy in pancreatic cancer
- Primary central nervous system lymphoma in immunocompetent patients
- Maintenance sunitinib or observation in metastatic pancreatic adenocarcinoma: A phase II randomised trial
- Quality assurance by systematic in vivo dosimetry: results on a large cohort of patients